Skip to main content

ProQR Therapeutics N.V.

PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612940

In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding ProQR Therapeutics N.V. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of PRQR: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6367+4
Shares38.5M39.8M+1.35M (+3.5%)
Value$259.4M$333.4M+$74.0M (+28.5%)

New holders (12)

Institutions that held ProQR Therapeutics N.V. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to PRQR in Q3 2021
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.457,900$3.83M0.02%
J. Goldman & Co LP196,500$1.65M0.15%
Altium Capital Management LP125,000$1.05M0.28%
Alpha Paradigm Partners, LLC44,323$371.0K0.15%
Copernicus Capital Management, LLC40,000$335.0K4.05%
Connor, Clark & Lunn Investment Management Ltd.38,359$321.0K0.00%
Great Point Partners LLC30,336$254.0K0.06%
Squarepoint Ops LLC18,049$151.0K0.00%
Jump Financial, LLC17,300$145.0K0.01%
Two Sigma Advisers, LP12,700$106.0K0.00%
Jane Street Group, LLC11,482$96.0K0.00%
Daiwa Securities Group Inc.10,665$89.0K0.00%

Sold out (8)

Institutions that held ProQR Therapeutics N.V. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of PRQR in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Sio Capital Management, LLC380,045$2.56M
Balyasny Asset Management LLC130,000$876.0K
Pinz Capital Management, LP18,700$126.0K
Equitable Holdings, Inc.15,000$101.0K
Virtu Financial LLC13,883$94.0K
Northern Trust Corp13,481$91.0K
Algert Global LLC11,300$76.0K
Acadian Asset Management LLC3,645$25.0K